Cargando…
Technetium-99m Radiopharmaceuticals for Ideal Myocardial Perfusion Imaging: Lost and Found Opportunities
The favorable nuclear properties in combination with the rich coordination chemistry make technetium-99m the radioisotope of choice for the development of myocardial perfusion tracers. In the early 1980s, [(99m)Tc]Tc-Sestamibi, [(99m)Tc]Tc-Tetrofosmin, and [(99m)Tc]Tc-Teboroxime were approved as com...
Autores principales: | Boschi, Alessandra, Uccelli, Licia, Marvelli, Lorenza, Cittanti, Corrado, Giganti, Melchiore, Martini, Petra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877792/ https://www.ncbi.nlm.nih.gov/pubmed/35208982 http://dx.doi.org/10.3390/molecules27041188 |
Ejemplares similares
-
Technetium Complexes and Radiopharmaceuticals with Scorpionate Ligands
por: Martini, Petra, et al.
Publicado: (2018) -
Influence of Storage Temperature on Radiochemical Purity of (99m)Tc-Radiopharmaceuticals
por: Uccelli, Licia, et al.
Publicado: (2018) -
Rhenium Radioisotopes for Medicine, a Focus on Production and Applications
por: Uccelli, Licia, et al.
Publicado: (2022) -
Oldie but Goodie:
Is Technetium-99m Still a Treasure
Trove of Innovation for Medicine? A Patents Analysis (2000–2022)
por: Riondato, Mattia, et al.
Publicado: (2023) -
Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008–2018)
por: Uccelli, Licia, et al.
Publicado: (2019)